Tysabri
Drug timelines are a Plus or Pro feature.
96 regulatory and trial events tracked for Tysabri, covering 2006-06-05 to 2026-07-06. Get the full timeline:
Most recent: EMA Authorised: Tysabri (natalizumab) — Biogen Netherlands B.V.
96 regulatory and trial events tracked for Tysabri, covering 2006-06-05 to 2026-07-06. Get the full timeline:
Most recent: EMA Authorised: Tysabri (natalizumab) — Biogen Netherlands B.V.